This is the authors' abstract. We don't add key points for this paper.
Based on our experience as a referral center for autosomal dominant polycystic kidney disease over the past 15 years,1 treating approximately 2000 patients from across Italy, we agree with the authors that familial variability in this disease necessitates a personalized approach.2 Variability is likely most pronounced in families with PKD1-nontruncating mutations, which may be less deterministic and more influenced by additional factors.3 Although the existing literature predominantly focuses on causal genetic aspects, the role of modifier genes within the same family remains largely underexplored.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Catania et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: